Tuberculosis
📧 Sign up to get email alerts when something new happens for Tuberculosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-03-03Clinical Trial Update: Host Response to Infection by Direct Analysis of Leukocyte Single Cell-type Gene Expression/transcript Abundance, Direct LS-TA
This clinical trial from the Chinese University of Hong Kong studies how host leukocytes respond to infections by analyzing single-cell gene…
-
CLINICAL_TRIALS research · 2025-03-03Clinical Trial Update: Host Response to Infection by Direct Analysis of Leukocyte Single Cell-type Gene Expression/transcript Abundance, Direct LS-TA. a Prospective Study Will Evaluate the Performance of Direct LS-TA in Triage Febrile Patients Into Major Categories of Infections: Viral, Bacterial or Active Tuberculosis.
A prospective study from The Chinese University of Hong Kong will evaluate Direct LS-TA using leukocyte single-cell gene expression to triag…
-
CLINICAL_TRIALS research · 2025-02-10Clinical Trial Update: Efficacy, Safety and Immunogenicity Evaluation of MTBVAC in Newborns in Sub-Saharan Africa [Phase 3]
Phase 3 clinical trial evaluating MTBVAC in newborns in Sub-Saharan Africa to assess efficacy, safety, and immunogenicity for tuberculosis. …
-
CLINICAL_TRIALS research · 2025-02-07Clinical Trial Update: Improving the Outcomes of Children With Tuberculosis Through Innovative Diagnostics and Treatment Monitoring
A clinical trial update focusing on improving outcomes for children with tuberculosis through innovative diagnostics and monitoring of treat…
-
CLINICAL_TRIALS research · 2025-02-06Clinical Trial Update: Phase II Clinical Study of Contezolid for the Treatment of Bone and Joint Tuberculosis [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating contezolid for bone and joint tuberculosis is currently enrolling at Beijing Chest Hospital.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-02-06Clinical Trial Update: Phase II Clinical Study of Contezolid for the Treatment of Tuberculous Meningitis [Phase 1, Phase 2]
An ongoing Phase I/II clinical trial of contezolid for tuberculous meningitis is currently enrolling by invitation.
-
CLINICAL_TRIALS research · 2025-01-22Clinical Trial Update: Lung Innate Immunity and Microbiome After Tuberculosis Exposure
Ongoing University of Oxford clinical trial investigates how the lung innate immune system and microbiome respond after exposure to tubercul…
-
CLINICAL_TRIALS research · 2025-01-08Clinical Trial Update: Patients With Tuberculosis, Mycobacteriosis or Latent Tuberculosis
A clinical trial examining patients with mycobacterial infections, tuberculosis, or latent tuberculosis is currently recruiting at IRCCS Azi…
-
CLINICAL_TRIALS research · 2024-12-27Clinical Trial Update: Design of an Integrative Algorithm for Staging Tuberculosis
The document describes the design of an integrative algorithm to stage tuberculosis and notes that recruitment is ongoing.
-
CLINICAL_TRIALS research · 2024-12-16Clinical Trial Update: Host Blood RNA Signatures for Diagnosis of TB
The University of Stellenbosch-sponsored trial evaluating host blood RNA signatures for diagnosing tuberculosis is currently active but not …
-
CLINICAL_TRIALS research · 2024-12-12Clinical Trial Update: Advice of Moderate Drinking Pattern Versus Advice on Abstention on Major Disease and Mortality [NA]
A clinical trial comparing moderate drinking to abstention is currently recruiting to evaluate effects on all-cause mortality and several ma…
-
CLINICAL_TRIALS research · 2024-12-11Clinical Trial Update: Phase I Clinical Protocol for Pre-evaluation of the Safety of BCG-PPD in Tuberculosis Patients [Phase 1]
Phase I clinical protocol update assessing the pre-evaluation safety of BCG-PPD in tuberculosis patients; the study is currently active but …
-
CLINICAL_TRIALS research · 2024-12-06Clinical Trial Update: Research on Key Interventional Technologies for Controlling the Epidemic in High-prevalence Areas of Tuberculosis in Guangxi, China [NA]
This clinical trial update describes a University of Toronto–sponsored interventional study in Guangxi, China, aiming to control tuberculosi…
-
CLINICAL_TRIALS research · 2024-12-05Clinical Trial Update: Strengthening Evidence on Optimal Multidrug-resistant Tuberculosis Treatment Regimens
Clinical trial update highlighting efforts to strengthen evidence for optimal multidrug-resistant tuberculosis regimens, including considera…
-
CLINICAL_TRIALS research · 2024-12-05Clinical Trial Update: DeMONSTRATE-TB Study in Ethiopia [Phase 2, Phase 3]
The DeMONSTRATE-TB study is a Phase 2/3 clinical trial being conducted in Ethiopia to evaluate strategies aimed at reducing tuberculosis inc…
-
CLINICAL_TRIALS research · 2024-11-29Clinical Trial Update: A Systemic Screening for TB Disease in High-risk Groups in Barcelona
A clinical trial in Barcelona is testing systemic screening for tuberculosis disease in high-risk groups. The study is currently recruiting.
-
CLINICAL_TRIALS research · 2024-11-29Clinical Trial Update: Immunocompetent Versus Immunocompromised Tuberculosis (TB) Patients
A clinical trial will compare outcomes in immunocompetent versus immunocompromised tuberculosis patients and is currently not yet recruiting…
-
CLINICAL_TRIALS research · 2024-11-22Clinical Trial Update: Pharmacokinetic Study of Sudapyridine（WX-081）in Healthy Chinese Subjects [Phase 1]
This is a Phase 1 pharmacokinetic study of sudapyridine (WX-081) in healthy Chinese subjects to characterize its PK profile for tuberculosis…
-
CLINICAL_TRIALS research · 2024-11-22Clinical Trial Update: Evaluation of IGRA, Symptoms and Chest Radiograph for Subclinical TB Detection in ESRD and KT
A recruiting clinical trial evaluating IGRA testing, symptom assessment, and chest radiography for detecting subclinical tuberculosis in pat…
-
CLINICAL_TRIALS research · 2024-11-05Clinical Trial Update: Evaluation of Different Diagnostic Methods of Tuberculosis in Assiut University Hospitals
A clinical trial update from Assiut University Hospitals evaluating different diagnostic methods for tuberculosis, with the study currently …
-
CLINICAL_TRIALS research · 2024-10-02Clinical Trial Update: Efficacy, Safety and Pharmacokinetics of DTG with RIF [Phase 2]
This Phase 2 trial is evaluating the efficacy, safety, and pharmacokinetics of dolutegravir with rifampin in people with HIV/TB coinfection …
-
CLINICAL_TRIALS research · 2024-10-01Clinical Trial Update: TB-CAPT MTB/XDR Study
Clinical trial update for the TB-CAPT MTB/XDR study. The current status is Active Not Recruiting and the sponsor is the Foundation for Innov…
-
CLINICAL_TRIALS research · 2024-10-01Clinical Trial Update: Safety of Administering Isoniazid to SLE Patients to Prevent TB [Phase 2, Phase 3]
A clinical trial update evaluating the safety of administering isoniazid to patients with systemic lupus erythematosus to prevent tuberculos…
-
CLINICAL_TRIALS research · 2024-09-26Clinical Trial Update: Evaluation of a CD4/CD8+ Interferon Gamma Release Assay for Monitoring Anti-Tuberculosis Treatment
This clinical trial evaluates a CD4/CD8+ Interferon Gamma Release Assay for monitoring anti-tuberculosis treatment, in patients with tubercu…
-
CLINICAL_TRIALS research · 2024-09-26Clinical Trial Update: Detection of Lipoarabinomannan in Urine Evaluation of the STANDARDTMF TBLAMFIA and Its Impact on the Initial TB Diagnosis
This clinical trial evaluates detection of lipoarabinomannan in urine using the STANDARD TB LAM FIA test and its impact on initial tuberculo…